Phospho-GATA3 (S308) Recombinant Monoclonal Antibody

Shipped with Ice Packs
In Stock

Description

Production Method

The antibody is generated using synthetic phosphopeptides corresponding to residues surrounding Ser308 of human GATA3. These peptides are used to immunize mice or transfect recombinant DNA into expression systems (e.g., HEK293 cells), ensuring specificity for the phosphorylated epitope .

Primary Uses

TechniqueDilution RangeKey ObservationsSource
Western Blot (WB)1:300–1:5000Detects ~48 kDa band in human/mouse/rat lysates (e.g., Jurkat, EL4, placenta)
Immunohistochemistry (IHC)1:50–1:400Nuclear staining in T-cells, placental trophoblasts, and transitional cell carcinoma
Immunoprecipitation (IP)1:70–1:100Confirmed specificity via phosphatase treatment (signal loss observed)
ELISA1:2000–1:10,000Quantitative detection of pSer308-GATA3 in lysates
Flow Cytometry1:50–1:200Intracellular staining in T-cell populations

Role of GATA3 Phosphorylation at Ser308

  1. T-Cell Differentiation:

    • Phosphorylation at Ser308 is linked to Th2 cell differentiation, enabling immune responses to allergens and pathogens .

    • Critical for regulating transcriptional activation of T-cell receptor genes .

  2. Cancer Biology:

    • In ER-positive breast cancer, Ser308 phosphorylation marks proteasomal degradation of GATA3, impacting tumor progression .

    • Observed in transitional cell carcinoma and placental tissues, suggesting diagnostic potential .

  3. Functional Validation:

    • Phosphatase Treatment: Exposure to lambda protein phosphatase abolishes antibody signal, confirming epitope specificity .

    • Cross-Species Utility: Effective in human, mouse, and rat models, expanding research scope .

Vendor Comparison

VendorCloneReactivityKey ApplicationsPrice (USD)
BiossN/AHuman, Mouse, RatWB, IHC-P~$210
Cosmo Bio USAClone 1E5HumanWB, IHC, ELISA~$210
AbcamEPR18118Human, Mouse, RatWB, IHC, IP, Dot Blot~$300
InvitrogenARC1560HumanWB, IHC~$526

Critical Considerations

  • Specificity: Ensure validation via phosphatase treatment or peptide competition assays .

  • Cross-Reactivity: Confirm species compatibility (e.g., human vs. mouse models) .

  • Dilution Optimization: Titrate primary antibody for optimal signal-to-noise ratio in IHC/WB .

Product Specs

Buffer
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Description

CUSABIO engineered a plasmid containing the phospho-GATA3 (S308) monoclonal antibody DNA sequence, which was then transfected into a cell line for expression. Immunizing mice with the synthetic phospho-peptide corresponding to residues surrounding Ser 308 of human GATA3 yielded the phospho-GATA3 (S308) monoclonal antibody. Subsequent affinity chromatography purification of the product led to the isolation of the recombinant phospho-GATA3 (S308) monoclonal antibody. It is a rabbit IgG antibody. This phospho-GATA3 (S308) antibody has been subjected to rigorous quality testing using ELISA, WB, and IHC techniques. It demonstrates reactivity with human samples. This anti-pSer308-GATA3 antibody can be effectively employed to elucidate the functional role of GATA3 phosphorylation.

GATA3, primarily expressed in T lymphocytes, plays a pivotal role in both early thymic T-cell development and the functional differentiation of naive CD4 T cells into Th2 cells. Numerous studies have identified GATA3, a T-cell transcription factor, as a key influencer in Th2 T-cell development. Moreover, it is implicated in mammary gland development and the maintenance of the differentiated state of luminal epithelial cells. The activity of GATA3 is subject to regulation by posttranslational modifications, the proteasome pathway, and phosphorylation. Notably, phosphorylation of GATA3 at Ser308 has been previously utilized as a marker of proteasomal turnover in ER-positive breast cancer cells.

Form
Liquid
Lead Time
Typically, we can dispatch products within 1-3 working days after receiving your order. Delivery time may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery times.
Synonyms
GATA 3 antibody; GATA binding factor 3 antibody; GATA binding protein 3 antibody; GATA-binding factor 3 antibody; Gata3 antibody; GATA3_HUMAN antibody; HDR antibody; HDRS antibody; MGC2346 antibody; MGC5199 antibody; MGC5445 antibody; Trans acting T cell specific transcription factor GATA 3 antibody; Trans-acting T-cell-specific transcription factor GATA-3 antibody
Target Names
Uniprot No.

Target Background

Function

GATA3 is a transcriptional activator that binds to the enhancer of the T-cell receptor alpha and delta genes. It recognizes the consensus sequence 5'-AGATAG-3'. GATA3 is essential for the T-helper 2 (Th2) differentiation process, which occurs following immune and inflammatory responses. It positively regulates the expression of ASB2.

Gene References Into Functions
  1. Evidence suggests that CRTh2 expression is regulated through the competitive action of GATA3 and NFAT1. PMID: 29969451
  2. This study proposes that genetic variation in the transcription factor GATA3, rather than STAT4, is associated with the risk of type 2 diabetes in the Bangladeshi population. PMID: 30044774
  3. One allele of the GATA3 second zinc finger leads to loss of binding and decreased expression at a subset of genes, including Progesterone Receptor. PMID: 29535312
  4. This study establishes a significant role for p38gamma MAPK in epithelial-mesenchymal transition (EMT) and identifies a novel signaling pathway for p38gamma MAPK-mediated tumor promotion. p38gamma MAPK regulates miR-200b by inhibiting GATA3 through inducing its ubiquitination, leading to proteasome-dependent degradation. PMID: 30251680
  5. Treg cells from asthmatic patients exhibit increased expression of both FOXP3 and GATA3; the expression level of GATA3 negatively correlates with FEV1%pred. Additionally, elevated expressions of USP21 and PIM2 were observed in Treg cells from asthmatic patients. PMID: 30013989
  6. GATA 3 emerges as a more sensitive marker than mammaglobin and GCDFP-15 for diagnosing metastatic breast carcinoma in cytological cell block materials. PMID: 29235613
  7. This study demonstrates consistent GATA-3 staining in walthard nests, rare staining in adenomatoid tumors, and infrequent positivity in normal urologic and gynecologic mesothelia. Furthermore, GATA-3 consistently stains positive in epididymi and negative in efferent ductules, which may reflect the embryological development of these tissues. PMID: 28582342
  8. GATA3 staining proves highly effective in distinguishing primary cutaneous apocrine cribriform carcinoma from skin breast cancer metastasis, exhibiting a high negative predictive value. PMID: 29431200
  9. GATA3 mutations, recently observed in breast cancer, encode active transcription factors. PMID: 30061207
  10. KMT1A positively regulates the self-renewal and tumorigenicity of human bladder cancer stem cells via the KMT1A-GATA3-STAT3 circuit, suggesting that KMT1A could be a promising therapeutic target for bladder cancer. PMID: 28765327
  11. Defective sirtuin-1 was found to increase IL-4 expression through acetylation of GATA-3 in patients with severe asthma compared to healthy controls. PMID: 26627546
  12. GATA3 activation was diminished upon cultivation of T cells with RNase 7. PMID: 28378334
  13. Overexpression of GATA3 and FOXA1 cooperates with PPAR activation to drive transdifferentiation of basal bladder cancer cells to a luminal phenotype. PMID: 27924948
  14. Data has shown that GATA3 is by far the most reliable breast-specific immunomarker in both surgical and cytological specimens. PMID: 28965624
  15. GATA3 interacts with and is acetylated by the acetyltransferase CBP. The primary acetylated site of GATA3 in lung adenocarcinoma cells is lysine 119. PMID: 29453984
  16. GATA3 may be useful as a component of a panel of immunohistochemical markers for narrowing the differential diagnosis between pheochromocytoma and adrenal cortical carcinoma. PMID: 28374498
  17. Researchers demonstrated that ER(alpha), GATA3, and FOXA1 form a transcriptional complex with Ell3 to regulate IL-20 expression in ER(+) breast cancer cells. FOXA1 represses IL-20 expression, while GATA3 and ER(alpha) activate it. PMID: 28514748
  18. ZPO2 has been identified as a negative regulator of GATA3, providing an alternative mechanism that may lead to a reduction in or even loss of GATA3 during breast cancer development. PMID: 28258171
  19. This study has demonstrated that GATA3 expression is prevalent in primary triple-negative breast carcinomas. PMID: 28211079
  20. GATA3 is a sensitive marker for primary genital extramammary paget disease. PMID: 28693610
  21. Benign prostate glands exhibiting radiation atypia show diffuse positivity for GATA3. PMID: 28316088
  22. This study documented transcriptional regulation of GATA3 in glioblastoma cells upon transfection with GAB sequence. PMID: 28614770
  23. Results indicate that GATA3, along with TRPS1, is distinctively overexpressed in breast cancer (BC) among all GATA family members and predicts better survival in patients with BC. GATA3 is therefore a distinct biomarker and essential prognostic factor in BC. PMID: 28423734
  24. Researchers observed high sensitivity for all the markers analyzed. Notably, the expression of NY-BR-1 and GATA-3 appeared most effective for labeling male breast cancer in both primary and metastatic settings. PMID: 29116378
  25. Findings suggest that high GATA3 expression is a predictor of poor prognosis in peripheral T cell lymphoma, and that T lymphoma cells promote M2-type macrophage differentiation through a GATA3-dependent mechanism. PMID: 27589565
  26. This study demonstrates that engagement of the T-cell receptor (TCR) on malignant T cells results in NF-kappaB activation and the upregulation of GATA-3 expression. Both mechanisms regulate the growth and survival of conventional T cells and have been shown to promote chemotherapy resistance in malignant T cells. PMID: 27780854
  27. These results indicate that the ELK3-GATA3 axis is a major pathway promoting metastasis of breast cancer MDA-MB-231 cells. PMID: 27556500
  28. As a transcriptionally regulated program, urothelial differentiation functions as a heterarchy, where GATA3 can cooperate with FOXA1 to drive expression of luminal marker genes, but P63 has the potential to transrepress expression of the same genes. PMID: 28282036
  29. Lymphocyte GATA-3 expression showed an increased level in elderly individuals compared to younger individuals. Women exhibited higher GATA-3 expression compared to men. PMID: 28509479
  30. C-MYC is linked to GATA3 and Ki-67 expression and is associated with a poor prognosis in nodal peripheral T-cell lymphomas. PMID: 27151990
  31. The GATA3 rs3824662 A allele and AA genotype may be risk factors for the development of pediatric ALL, particularly B-ALL, in the studied cohort of Egyptian patients. The AA genotype is associated with shorter DSF, increased relapse incidence, and poor prognosis in pediatric ALL. PMID: 27684731
  32. Mutation in the GATA-3 gene is linked to hypoparathyroidism, deafness, and renal dysplasia syndrome. PMID: 27387476
  33. GATA3 serves as a reliable diagnostic marker for Neuroblastomas, not only in scant/limited surgical specimens but also in cytological samples, including air-dried touch imprints, which were previously undocumented for this marker. PMID: 28976719
  34. Dysregulation of JAM-A via the p63/GATA-3 signaling pathway occurs in squamous cell carcinomas of the head and neck. PMID: 27036044
  35. FBXW7alpha inhibits breast cancer cell survival by promoting GATA3 degradation/destabilizing GATA3. PMID: 28722108
  36. GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression. PMID: 27267060
  37. MIR-720 suppresses M2 macrophage polarization by targeting GATA3; MIR-720 is down-regulated in breast cancer macrophages. PMID: 27354564
  38. The model of mutually antagonistic differentiation programs driven by mutually exclusively expressed T-bet or GATA-3 does not completely explain natural CD4 T cell priming outcomes. PMID: 29088218
  39. GATA3 expression is associated with breast carcinomas of luminal subtype and low histological grade. PMID: 28428285
  40. This study aimed to investigate the clinical significance of three immune cell-related transcription factors, T-bet, GATA-3, and Bcl-6 in bladder cancer in Tunisian patients. PMID: 27237631
  41. Data clarifies the regulatory mechanisms of GATA3 in DNA double-strand breaks repair and strongly suggests that it might act as a tumor suppressor by promoting CtIP expression and homologous recombination to stabilize genomes. PMID: 28481869
  42. This study provides new insights into the role of SEMA3B in the mammary gland and presents a new branch of GATA3 signaling that is crucial for inhibiting breast cancer progression and metastasis. PMID: 28581515
  43. This gene's expression is up-regulated by the EP300-ZNF384 fusion gene product. PMID: 28378055
  44. Coexpression of GATA3 and CK7 in most clear cell papillary renal cell carcinomas provides evidence of their origin from the distal nephron and can be used in differential diagnosis. PMID: 28705707
  45. Findings suggest that GATA3 stabilizes HIF-1alpha to enhance cancer invasiveness under hypoxic conditions. PMID: 28263977
  46. GATA-3 is a sensitive and specific marker for diagnosing acute leukemias with T-cell differentiation. PMID: 28551327
  47. In resected lung adenocarcinoma, high GATA3 expression is associated with poorer prognosis for both overall survival and disease-free survival. PMID: 28322854
  48. Loss of GATA3 expression was found to be an independent predictor of poor patient outcomes in bladder urothelial carcinoma. PMID: 28428106
  49. Meta-analysis revealed that high expression of GATA3 in breast cancer is associated with improved time to tumor progression. PMID: 28394898
  50. Rs17144046, located near GATA3, was significantly associated with benign prostatic hyperplasia and lower urinary tract symptoms. PMID: 28656603

Show More

Hide All

Database Links

HGNC: 4172

OMIM: 131320

KEGG: hsa:2625

STRING: 9606.ENSP00000368632

UniGene: Hs.524134

Involvement In Disease
Hypoparathyroidism, sensorineural deafness, and renal disease (HDR)
Subcellular Location
Nucleus.
Tissue Specificity
T-cells and endothelial cells.

Q&A

What is the functional significance of GATA3 phosphorylation at Serine 308?

Phosphorylation of GATA3 at Serine 308 serves as a key regulatory mechanism affecting its transcriptional activity and protein stability. This post-translational modification has significant implications for T-cell development and differentiation pathways. GATA3 phosphorylation at S308 has been established as a marker of proteasomal turnover specifically in ER-positive breast cancer cells . This phosphorylation event alters GATA3 activity, influencing its role in coordinating macrophage transcriptional activation and UCP2-dependent metabolic reprogramming in response to IL33 signaling . Furthermore, phosphorylation at this residue appears to modulate GATA3's function in driving the differentiation of inflammation-resolving alternatively activated macrophages following tissue injury .

In which research applications can Phospho-GATA3 (S308) antibodies be utilized?

Phospho-GATA3 (S308) recombinant monoclonal antibodies demonstrate versatility across multiple experimental applications:

ApplicationValidatedRecommended DilutionNotes
Western Blot (WB)Yes1:500-1:5000 or 1:10000 Effective for detecting phosphorylated GATA3 in cell lysates
Immunohistochemistry (IHC-P)Yes1:50-1:200 Works on paraffin-embedded tissues
Immunoprecipitation (IP)YesAs recommended by manufacturerUseful for protein interaction studies
Dot BlotYesAs recommended by manufacturerSuitable for rapid detection
Flow CytometryYesAs recommended by manufacturerFor cellular analysis

These applications allow researchers to investigate GATA3 phosphorylation in various experimental contexts, from protein expression analysis to cellular localization studies .

What species reactivity has been confirmed for these antibodies?

Phospho-GATA3 (S308) antibodies have been validated for reactivity with multiple species:

  • Human samples: Extensively tested and confirmed

  • Mouse samples: Confirmed reactivity

  • Rat samples: Confirmed reactivity

This multi-species reactivity makes these antibodies valuable for comparative studies across experimental models, though researchers should verify reactivity when using new sample types or experimental conditions .

How should researchers optimize Western blot conditions for Phospho-GATA3 (S308) detection?

For optimal Western blot results with Phospho-GATA3 (S308) antibodies, implement the following protocol adjustments:

  • Sample preparation: Use phosphatase inhibitors in lysis buffers to preserve phosphorylation status

  • Blocking conditions: Employ 5% non-fat dry milk (NFDM) in TBST as recommended blocking buffer

  • Antibody dilution: Start with 1:1000 dilution for initial optimization, then adjust based on signal intensity (recommended range 1:500-1:10000)

  • Positive controls: Include samples known to express phosphorylated GATA3, such as Jurkat cells treated with 8-Bromo-cAMP

  • Loading controls: Use appropriate housekeeping proteins that won't interfere with phosphorylated protein detection

These optimization steps ensure specific detection of phosphorylated GATA3 while minimizing background signal and false positives .

What are the critical storage conditions for maintaining antibody performance?

Proper storage is essential for preserving antibody functionality:

  • Short-term storage (up to 2 weeks): Store at 4°C

  • Long-term storage: Aliquot and store at -20°C

  • Avoid freeze-thaw cycles to prevent antibody degradation

  • For carrier-free formulations (BSA and azide-free), additional stabilizing agents may be necessary for prolonged storage

Following these storage recommendations ensures antibody integrity and consistent experimental performance over time .

How can Phospho-GATA3 (S308) antibodies be utilized to investigate T-helper cell differentiation mechanisms?

GATA3 is essential for T-helper 2 (Th2) cell differentiation, and its phosphorylation status affects this process. Researchers can employ these advanced methodologies:

  • Time-course experiments: Monitor phosphorylation changes during T-cell activation using flow cytometry and Western blotting

  • Cytokine stimulation studies: Examine how IL-4, IL-33, and other Th2-promoting cytokines affect GATA3 phosphorylation

  • Knockin/knockout approach: Compare wild-type GATA3 with phospho-mutants (S308A) to assess functional consequences

  • ChIP-seq analysis: Determine how S308 phosphorylation affects GATA3 binding to target genes using the antibody for chromatin immunoprecipitation

  • Single-cell analysis: Combine phospho-GATA3 detection with other markers to identify cellular subpopulations

These approaches can reveal how GATA3 phosphorylation contributes to T-cell lineage commitment and function in immune responses .

What mechanisms regulate GATA3 phosphorylation at S308, and how can they be experimentally investigated?

GATA3 phosphorylation at S308 is regulated through multiple mechanisms:

Regulatory MechanismExperimental ApproachExpected Outcome
p38 MAPK pathwayInhibitor studies (SB203580)Decreased S308 phosphorylation
PKA signalingcAMP analogs (8-Bromo-cAMP)Enhanced phosphorylation
Protein phosphatasesPhosphatase inhibitorsSustained phosphorylation
Proteasomal degradationProteasome inhibitors (MG132)Accumulation of phosphorylated GATA3

For comprehensive analysis, researchers should combine these approaches with time-course studies and quantitative Western blotting or ELISA to measure phosphorylation dynamics. Additionally, mass spectrometry can identify other phosphorylation sites that may cross-talk with S308 .

How does GATA3 phosphorylation at S308 contribute to breast cancer biology?

In ER-positive breast cancer cells, GATA3 phosphorylation at S308 functions as a marker of proteasomal turnover . This phosphorylation event has significant implications for breast cancer biology:

  • Correlation with tumor progression: Immunohistochemistry using phospho-specific antibodies can reveal associations between phosphorylation status and clinical outcomes

  • Estrogen signaling: Experiments combining estrogen treatment with phospho-GATA3 detection can elucidate regulatory mechanisms

  • Therapeutic response: Monitoring phospho-GATA3 levels during treatment with proteasome inhibitors or hormone therapies may predict response

  • Transcriptional programming: RNA-seq analysis following modulation of GATA3 phosphorylation can identify downstream gene targets

  • Metastatic potential: Investigation of phospho-GATA3 in primary versus metastatic samples may reveal its role in disease progression

These research approaches can determine whether targeting GATA3 phosphorylation might offer therapeutic opportunities in breast cancer treatment .

What are the common pitfalls in phospho-specific antibody experiments, and how can they be mitigated?

When working with Phospho-GATA3 (S308) antibodies, researchers should be aware of these potential issues:

  • Cross-reactivity concerns: The immunogen sequence for this antibody is identical to the sequence around S340 of GATA2, although phosphorylation at this site has not been reported . Include appropriate negative controls to ensure specificity.

  • Phosphorylation preservation: Phosphorylation can be lost during sample preparation. Always use fresh phosphatase inhibitors in lysis buffers and handle samples at 4°C.

  • Antibody specificity verification: Validate specificity using:

    • Phosphatase treatment controls

    • Peptide competition assays

    • Phospho-null mutants (S308A)

  • Signal optimization: For weak signals:

    • Increase antibody concentration gradually

    • Extend incubation time

    • Use signal enhancement systems like biotin-streptavidin

  • Background reduction: If high background occurs:

    • Try alternative blocking buffers (5% BSA instead of milk)

    • Increase washing time and volume

    • Reduce primary antibody concentration

These approaches ensure reliable, reproducible results when investigating GATA3 phosphorylation .

How can researchers quantitatively assess GATA3 phosphorylation levels?

For quantitative analysis of GATA3 phosphorylation:

  • Western blot quantification:

    • Use total GATA3 antibody in parallel for normalization

    • Apply densitometry analysis with appropriate software

    • Include standard curves with recombinant phosphorylated protein

  • Flow cytometry approach:

    • Perform dual staining with total and phospho-specific antibodies

    • Calculate phosphorylation index as ratio of phospho/total signal

    • Include appropriate isotype controls

  • ELISA-based methods:

    • Develop sandwich ELISA with capture/detection antibody pairs

    • Create standard curves using recombinant proteins

    • Calculate phosphorylation ratios across experimental conditions

  • Mass spectrometry:

    • Perform immunoprecipitation with total GATA3 antibody

    • Analyze phosphopeptides by LC-MS/MS

    • Quantify phosphorylation stoichiometry

These quantitative approaches provide robust data for comparing GATA3 phosphorylation across experimental conditions .

How might single-cell analysis techniques be applied to investigate heterogeneity in GATA3 phosphorylation?

Single-cell technologies offer powerful approaches for examining GATA3 phosphorylation heterogeneity:

  • Single-cell phospho-flow cytometry:

    • Combine phospho-GATA3 (S308) detection with lineage markers

    • Identify cell subpopulations with distinct phosphorylation states

    • Correlate with functional outcomes

  • Mass cytometry (CyTOF):

    • Develop metal-conjugated phospho-GATA3 antibodies

    • Simultaneously measure multiple phosphorylation sites

    • Create high-dimensional datasets to identify cellular states

  • Imaging mass cytometry:

    • Visualize spatial distribution of phosphorylated GATA3 in tissues

    • Correlate with microenvironmental factors

  • Single-cell RNA-seq integration:

    • Combine phospho-protein detection with transcriptomic analysis

    • Identify gene expression signatures associated with phosphorylation states

These approaches can reveal how heterogeneous GATA3 phosphorylation contributes to cellular diversity in immune responses and cancer .

What is the relationship between GATA3 phosphorylation at S308 and its role in macrophage polarization?

GATA3 coordinates macrophage transcriptional activation and metabolic reprogramming in response to IL33, with phosphorylation potentially modulating this activity . To investigate this relationship:

  • Macrophage differentiation models:

    • Monitor phospho-GATA3 levels during M1/M2 polarization

    • Compare phosphorylation in tissue-resident versus inflammatory macrophages

    • Assess how IL-33 signaling affects phosphorylation kinetics

  • Functional consequences:

    • Express phospho-mimetic (S308D) or phospho-null (S308A) GATA3 mutants

    • Measure impact on UCP2 expression and metabolic parameters

    • Assess effects on anti-inflammatory cytokine production

  • In vivo relevance:

    • Examine phospho-GATA3 in tissue injury and resolution models

    • Correlate with macrophage phenotypic markers

    • Assess impact of phosphorylation inhibitors on inflammation resolution

These investigations could reveal how GATA3 phosphorylation serves as a molecular switch in macrophage functional programming during inflammation and tissue repair .

How does phosphorylation at S308 compare with other GATA3 post-translational modifications?

GATA3 undergoes multiple post-translational modifications that collectively regulate its function:

ModificationSiteFunctional ImpactRelationship to S308 Phosphorylation
PhosphorylationS308Proteasomal turnover, activity regulation-
AcetylationK305Enhances DNA bindingPotential cross-talk due to proximity
SUMOylationK156Alters transcriptional activityMay affect stability independently
UbiquitinationMultipleTargets for degradationLikely regulated by S308 phosphorylation
MethylationR261Modulates protein interactionsUnknown relationship

Researchers can investigate these relationships through:

  • Sequential immunoprecipitation with modification-specific antibodies

  • Mass spectrometry to identify modification patterns

  • Mutational studies examining how one modification affects others

This integrated approach provides a comprehensive understanding of GATA3 regulation in different cellular contexts .

How can computational approaches be integrated with phospho-GATA3 antibody data?

Computational methods enhance the value of experimental phospho-GATA3 data:

  • Structural modeling:

    • Predict how S308 phosphorylation affects protein conformation

    • Model interactions with DNA and protein partners

    • Simulate dynamic changes in protein structure

  • Systems biology approaches:

    • Integrate phosphorylation data into signaling network models

    • Predict downstream effects using pathway analysis

    • Model temporal dynamics of phosphorylation/dephosphorylation

  • Machine learning applications:

    • Develop pattern recognition algorithms for image analysis

    • Create predictive models for phosphorylation based on cellular context

    • Identify biomarker signatures incorporating phospho-GATA3 data

  • Multi-omics integration:

    • Correlate phosphorylation status with transcriptomic, proteomic, and metabolomic data

    • Construct regulatory networks with phospho-GATA3 as a node

These computational strategies extend the utility of experimental data and generate hypotheses for further investigation .

What are the technical differences between available Phospho-GATA3 (S308) antibody clones?

Several manufacturers produce Phospho-GATA3 (S308) antibodies with distinct characteristics:

Clone/ProductHostProduction MethodValidated ApplicationsSpecial Features
EPR18118 (Abcam)RabbitRecombinant monoclonalWB, IP, Dot, IHC-PAvailable in carrier-free format for conjugation
CUSABIORabbitRecombinant monoclonalWB, IHC, ELISAProduced using synthetic phospho-peptide immunization
AbnovaIgGMonoclonalFlow CytometryValidated for flow applications
SigmaRabbitNot specifiedNot specifiedDifferent format options

When selecting between these options, researchers should consider:

  • The specific application requirements

  • Whether conjugation to reporters is needed

  • The experimental model system

  • The degree of validation required for their research

Each antibody may perform differently in specific applications, so preliminary validation is recommended .

How can researchers validate antibody specificity for phosphorylated versus non-phosphorylated GATA3?

Thorough validation of phospho-specificity is crucial:

  • Peptide competition assays:

    • Pre-incubate antibody with phosphorylated and non-phosphorylated peptides

    • Only phospho-peptides should block specific binding

  • Phosphatase treatment:

    • Treat one sample set with lambda phosphatase

    • Signal should disappear in treated samples

  • Genetic validation:

    • Express wild-type GATA3 versus S308A mutant

    • No signal should be detected with the S308A mutant

  • Stimulus-response validation:

    • Treat cells with stimuli known to induce phosphorylation (e.g., 8-Bromo-cAMP)

    • Signal should increase in treated samples

  • Western blot migration patterns:

    • Phosphorylated proteins often show mobility shifts

    • Confirm band identity through multiple approaches

These validation steps ensure experimental results accurately reflect GATA3 phosphorylation status rather than non-specific binding .

How might Phospho-GATA3 (S308) detection be integrated into multiplexed imaging approaches?

Multiplexed imaging technologies offer powerful ways to study GATA3 phosphorylation in spatial context:

  • Multiplex immunofluorescence:

    • Combine phospho-GATA3 with lineage markers and other phospho-proteins

    • Use spectral unmixing to separate fluorophores

    • Apply tissue clearing techniques for 3D imaging

  • Mass spectrometry imaging:

    • Utilize metal-tagged antibodies for spatial proteomics

    • Achieve subcellular resolution of phosphorylation patterns

    • Correlate with tissue architecture

  • Cyclic immunofluorescence:

    • Perform sequential staining/stripping cycles

    • Build high-parameter datasets within the same tissue section

    • Create spatial maps of signaling networks

  • In situ proximity ligation assay:

    • Detect phospho-GATA3 interactions with other proteins

    • Visualize subcellular localization of interaction events

    • Quantify interaction frequency across cell populations

These approaches reveal not just whether GATA3 is phosphorylated but also its spatial relationships with other cellular components .

What role might GATA3 phosphorylation play in novel therapeutic approaches?

Understanding GATA3 phosphorylation mechanisms opens new therapeutic possibilities:

  • Targeted inhibition approaches:

    • Design small molecules targeting kinases that phosphorylate S308

    • Develop peptide inhibitors that prevent phosphorylation

    • Create proteolysis-targeting chimeras (PROTACs) specific for phospho-GATA3

  • Diagnostic applications:

    • Develop phospho-GATA3 detection in liquid biopsies

    • Create companion diagnostics for breast cancer treatments

    • Establish prognostic scoring systems incorporating phosphorylation status

  • Immunotherapy connections:

    • Investigate how T-cell GATA3 phosphorylation affects immunotherapy response

    • Explore manipulation of GATA3 phosphorylation to enhance anti-tumor immunity

    • Study macrophage reprogramming through GATA3 phosphorylation modulation

  • Cell-based therapeutics:

    • Engineer T-cells with phospho-mimetic or phospho-null GATA3 for enhanced function

    • Modify regulatory T-cells through GATA3 phosphorylation manipulation

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.